Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors: A Systematic Review
Authors' conclusion
FCR is common in thyroid cancer survivors, but significant heterogeneity in the current evidence base limits assessment of incidence, severity, or risk factors.
Study context
- Population
- DTC survivors; English literature, six electronic databases31 studies
- Outcome
- Incidence of fear of cancer recurrence (FCR)
Pooled result
As reported in the abstract
Incidence of FCR
Incidence of fear of cancer recurrence (FCR) (reported in 27/31 studies), range
15% to 91%
Further pooled results
Tools used to measure FCR
- Validated tools used across all studies
- 8
- Studies using self-developed nonvalidated items
- 5
- Minimal repetition of validated tools; no clear consensus on a preferred survey tool
Factors influencing FCR
- Studies reporting factors influencing FCR
- 11
- Risk factors for increased FCR in >1 study: young age, upcoming clinical appointment
- Protective in >1 article: male gender, higher education
- No literature evaluating interventions to address FCR found
Original publication
Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors: A Systematic Review. Thyroid. Published 18 March 2024. doi:10. 1089/ thy. 2023. 0642
Composed by AI from the published abstract and checked against it. How Briefs are made →